Kerndatensatz Senologie - Local Development build (v0.9.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• JSON

: Fall 2: Tumorboard bei Progression - JSON Representation

Raw json | Download

{
  "resourceType" : "CarePlan",
  "id" : "Fall2-Tumorboard-Progression",
  "meta" : {
    "profile" : [
      🔗 "https://www.senologie.org/fhir/StructureDefinition/senologie-tumorboard-empfehlung"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CarePlan Fall2-Tumorboard-Progression</b></p><a name=\"Fall2-Tumorboard-Progression\"> </a><a name=\"hcFall2-Tumorboard-Progression\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-senologie-tumorboard-empfehlung.html\">BIH Senologie Tumorboard Empfehlung</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Plan</p><p><b>category</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ postth}\">posttherapeutisch</span></p><p><b>title</b>: Tumorboard-Empfehlung Lena Hoffmann — Progression</p><p><b>description</b>: Hepatische Metastasen nach 18 Monaten. Empfehlung: Umstellung auf palliatives Therapiekonzept. Sacituzumab govitecan als Zweitlinientherapie. Best Supportive Care.</p><p><b>subject</b>: <a href=\"Patient-Fall2-Patient-Lena-Hoffmann.html\">Lena Hoffmann  Female, DoB: 1980-09-28 ( http://fhir.bih-charite.de/sid/patient-id#SENO-2025-002)</a></p><p><b>period</b>: 2026-08-15 --&gt; (ongoing)</p><p><b>addresses</b>: <a href=\"Condition-Fall2-Diagnose-Mammakarzinom.html\">Condition Malignant neoplasm of breast</a></p><blockquote><p><b>activity</b></p><h3>Details</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Kind</b></td><td><b>Code</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td>MedicationRequest</td><td><span title=\"Codes:{http://snomed.info/sct 385786002}\">Sacituzumab govitecan (Trodelvy) 10 mg/kg d1,8 q3w</span></td><td>Scheduled</td></tr></table></blockquote><blockquote><p><b>activity</b></p><h3>Details</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Kind</b></td><td><b>Code</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td>Appointment</td><td><span title=\"Codes:{http://snomed.info/sct 390906007}\">Anbindung Palliativmedizin, psychoonkologische Betreuung</span></td><td>Scheduled</td></tr></table></blockquote><p><b>note</b>: </p><blockquote><div><p>Palliativkonzept empfohlen. PD-L1-Retest empfohlen.</p>\n</div></blockquote></div>"
  },
  "status" : "active",
  "intent" : "plan",
  "category" : [
    {
      "coding" : [
        {
          "system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
          "code" : "postth",
          "display" : "posttherapeutisch"
        }
      ]
    }
  ],
  "title" : "Tumorboard-Empfehlung Lena Hoffmann — Progression",
  "description" : "Hepatische Metastasen nach 18 Monaten. Empfehlung: Umstellung auf palliatives Therapiekonzept. Sacituzumab govitecan als Zweitlinientherapie. Best Supportive Care.",
  "subject" : {
    🔗 "reference" : "Patient/Fall2-Patient-Lena-Hoffmann"
  },
  "period" : {
    "start" : "2026-08-15"
  },
  "addresses" : [
    {
      🔗 "reference" : "Condition/Fall2-Diagnose-Mammakarzinom"
    }
  ],
  "activity" : [
    {
      "detail" : {
        "kind" : "MedicationRequest",
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "385786002",
              "display" : "Chemotherapy care (regime/therapy)"
            }
          ],
          "text" : "Sacituzumab govitecan (Trodelvy) 10 mg/kg d1,8 q3w"
        },
        "status" : "scheduled"
      }
    },
    {
      "detail" : {
        "kind" : "Appointment",
        "code" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "390906007",
              "display" : "Follow-up encounter (procedure)"
            }
          ],
          "text" : "Anbindung Palliativmedizin, psychoonkologische Betreuung"
        },
        "status" : "scheduled"
      }
    }
  ],
  "note" : [
    {
      "text" : "Palliativkonzept empfohlen. PD-L1-Retest empfohlen."
    }
  ]
}